Insider Transactions in Q1 2026 at Milestone Pharmaceuticals Inc. (MIST)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 26
2026
|
Joseph Oliveto President and CEO |
SELL
Open market or private sale
|
Direct |
34,523
-6.67%
|
$34,523
$1.93 P/Share
|
|
Jan 26
2026
|
Joseph Oliveto President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
66,600
+11.41%
|
-
|
|
Jan 26
2026
|
Amit Hasija CFO & EVP of Corp. Development |
SELL
Open market or private sale
|
Direct |
12,245
-10.92%
|
$12,245
$1.93 P/Share
|
|
Jan 26
2026
|
Amit Hasija CFO & EVP of Corp. Development |
BUY
Exercise of conversion of derivative security
|
Direct |
20,100
+15.21%
|
-
|
|
Jan 26
2026
|
Lorenz Muller Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,180
-5.16%
|
$11,180
$1.93 P/Share
|
|
Jan 26
2026
|
Lorenz Muller Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,100
+8.49%
|
-
|
|
Jan 26
2026
|
Jeffrey Edward Nelson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,245
-19.72%
|
$12,245
$1.93 P/Share
|
|
Jan 26
2026
|
Jeffrey Edward Nelson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,100
+24.45%
|
-
|
|
Jan 26
2026
|
David Bharucha Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,245
-9.76%
|
$12,245
$1.93 P/Share
|
|
Jan 26
2026
|
David Bharucha Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,100
+13.81%
|
-
|
|
Jan 08
2026
|
Joseph Oliveto President and CEO |
SELL
Open market or private sale
|
Direct |
43,000
-12.4%
|
$86,000
$2.25 P/Share
|
|
Jan 07
2026
|
Joseph Oliveto President and CEO |
SELL
Open market or private sale
|
Direct |
500
-0.14%
|
$1,000
$2.25 P/Share
|